LESLIE LATTIN: Open Payments
NPI 1194275099 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 114 payments from 20 companies in 2025. Trend: 2023 $1,372 · 2024 $1,548 · 2025 $1,542
Food & beverage: $1,542
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $167 |
| Novo Nordisk Inc | 19 | $165 |
| Lilly USA, LLC | 15 | $158 |
| Amgen Inc. | 24 | $154 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| Dexcom, Inc. | 6 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
| ABBVIE INC. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $63 |
Products named: Dexcom G6 Transmitter, ELIQUIS, OTEZLA, LEQVIO, MOUNJARO, AIRSUPRA, Wegovy, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
